Pirfenidone


( Last Updated : August 29, 2014)
Generic Name:
Pirfenidone
Project Status:
Complete
Therapeutic Area:
Idiopathic pulmonary fibrosis
Manufacturer:
Hoffmann-La Roche Ltd.
Call for patient/clinician input open:
Brand Name:
Esbriet
Project Line:
Reimbursement Review
Project Number:
SR0393-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Resubmission
Indications:
Pulmonary fibrosis (idiopathic, mild to moderate)
Recommendation Type:
List with criteria/condition
Final Recommendation: